Director, Opinion Leader and Ambassador Strategy

BioMarin is a leading rare disease biotechnology company focused on genetically defined conditions. Guided by our purpose to develop medicines that make a profound impact on people’s lives, our global teams have delivered a portfolio of therapies since our founding in 1997. Our revolutionary treatments for conditions like achondroplasia (the most common form of dwarfism), PKU (phenylketonuria), CLN2, a form of Batten disease, and a number of forms of MPS (mucopolysaccharidosis) offer new possibilities for patients and families who previously had few, if any, available options. More recently, with the close of the Amicus acquisition, our portfolio has expanded to include therapies for Fabry disease and Pompe disease, expanding our ability to reach more people living with rare genetic conditions. Our success comes from our unwavering commitment to excellence, our deep understanding of patient needs, our scientific expertise, and our world-class manufacturing capabilities. At the heart of BioMarin is a dedicated team of the brightest minds in the industry working together to deliver innovative therapies to patients and families around the world. About Commercial Be part of the worldwide infrastructure that gets our drugs to underserved patients around the world. Our global sales force solidifies BioMarin’s commercial presence in the United States and Europe and is rapidly growing in other regions, such as South America, EuMEA, and Asia-Pacific.

Summary The Director, Opinion Leader and Ambassador Strategy will lead the development and execution of a portfolio-wide strategy to identify, understand, engage, and cultivate healthcare professional opinion leaders and patient ambassadors across BioMarin’s U.S. Metabolic Conditions Business Unit. The role will build durable, compliant relationships with established and emerging external experts; translate stakeholder insights into actionable commercial strategy; and expand the quality, reach, and impact of peer-to-peer education across rare metabolic diseases. Operating at the intersection of brand strategy, field engagement, peer-to-peer programming, congress planning, and customer insight, the Director will establish a consistent engagement model across brands while adapting plans to the needs of each disease community. The successful candidate will combine the external orientation and relationship-building discipline typical of a Thought Leader Liaison with strong marketing judgment, portfolio leadership, people management, and operational accountability. This role will partner closely with Brand Marketing, Sales, Medical Affairs, Patient Advocacy, Legal, Regulatory, Compliance, Commercial Operations, Analytics, and agency partners to ensure engagements are purposeful, coordinated, compliant, and connected to business and patient needs. This role will report directly to the Head of Marketing, U.S. Metabolic Conditions, and will have two direct reports. Key Responsibilities •    Set and execute the portfolio-wide opinion leader and ambassador strategy across U.S. Metabolic Conditions, aligning stakeholder priorities to brand and business objectives. •    Build trusted, compliant relationships with established and emerging healthcare professionals through targeted field engagement, congresses, advisory forums, and other approved channels. •    Create stakeholder segmentation and engagement plans that define objectives, coordinated touchpoints, relationship milestones, and cross-functional roles. •    Develop and maintain a dynamic stakeholder influence map across disease-state experts, treating physicians, advocacy leaders, patient ambassadors, caregivers, and emerging digital influencers to identify opportunities, gaps, and future engagement priorities. •    Evaluate and leverage evolving digital engagement channels and influence networks to extend the reach, relevance, and impact of peer-to-peer and ambassador engagement programs. •